COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,599 Articles (22,905 medRxiv, 8,694 bioRxiv)

Most recent first Previous |  Page 1954: Articles 19531-19540  | Next

State-level COVID-19 Trend Forecasting Using Mobility and Policy Data
Wang, Y., Peng, H., Sha, L., Liu, Z., Hong, P.
10.1101/2021.01.04.21249218 — Posted: 2021-01-06
Modeling COVID-19 outbreaks in United States with distinct testing, lockdown speed and fatigue rates
Gulbudak, H., Browne, C., Macdonald, J. C.
10.1101/2021.01.04.21249231 — Posted: 2021-01-06
Reverse Transcriptase Loop Mediated Isothermal Amplification (RT-LAMP) for COVID-19 Diagnosis: A Systematic Review and Meta-Analysis
Subali, A. D., Wiyono, L.
10.1101/2021.01.04.20248979 — Posted: 2021-01-06
Use of the FebriDx point-of-care assay as part of a triage algorithm for medical admissions with possible COVID-19
Houston, H., Gupta-Wright, A., Deas, G., Naik, S., Shah, K., Patel, S., Dottori, M. G., Tay, M., Filson, S., Biggin-Lamming, J., Ross, J., Vaughan, N., Vaid, N., Gopal Rao, G., Amin, A., John, L.
10.1101/2021.01.05.21249154 — Posted: 2021-01-06
Coronavirus-19 and coagulopathy: A Systematic Review
Lee, S. G., Fralick, M., Tang, G., Tse, B., Baumann Kreuziger, L., Cushman, M., Juni, P., Sholzberg, M.
10.1101/2021.01.05.20248202 — Posted: 2021-01-06
The Effect of Frames on COVID-19 Vaccine Hesitancy
Palm, R., Bolsen, T., Kingsland, J.
10.1101/2021.01.04.21249241 — Posted: 2021-01-06
Covid19Risk.ai: An open source repository and online calculator of prediction models for early diagnosis and prognosis of Covid-19
Halilaj, I., Chatterjee, A., Wijk, Y. v., Wu, G., Eeckhout, B. v., Oberije, C., Lambin, P.
10.1101/2021.01.05.425384 — Posted: 2021-01-05
In-Vitro Fluorescence Microscopy Studies Show Retention of Spike-Protein (SARS-Cov-2) on Cell Membrane in the Presence of Amodiaquin Dihydrochloride Dihydrate Drug
Mondal, P. P., Mandal, S.
10.1101/2021.01.05.424956 — Posted: 2021-01-05
Molecular Mechanism of the N501Y Mutation for Enhanced Binding between SARS-CoV-2's Spike Protein and Human ACE2 Receptor
Luan, B., Wang, H., Huynh, T.
10.1101/2021.01.04.425316 — Posted: 2021-01-05
Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mice and non-human primates
Zabaleta, N., Dai, W., Bhatt, U., Chichester, J. A., Estelien, R., Sanmiguel, J., Michalson, K. T., Diop, C., Maciorowski, D., Qi, W., Hudspeth, E., Cucalon, A., Dyer, C. D., Pampena, M. B., Knox, J. J., LaRocque, R. C., Charles, R. C., Li, D., Kim, M., Sheridan, A., Storm, N., Johnson, R. I., Feldman, J., Hauser, B. M., Ryan, A., Kobayashi, D. T., Chauhan, R., McGlynn, M., Ryan, E. T., Schmidt, A. G., Price, B., Honko, A., Griffiths, A., Yaghmour, S., Hodge, R., Betts, M. R., Freeman, M. W., Wilson, J. M., Vandenberghe, L. H.
10.1101/2021.01.05.422952 — Posted: 2021-01-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).